Therefore, we further investigated whether the synergistic reduction of cAMP level by the combinations of IFN-α and inhibitors of TPL2-MEK-PDE4D pathway have effects on the proliferation of bladder cancer cells. The gene discussed is IFNA1; the disease is urinary bladder carcinoma.